Roswell Biotech develops biotechnology platforms integrating semiconductor technology with molecular biology for life science applications. The company creates innovative biosensor technologies that enable single-molecule detection and analysis at scale, bridging the gap between electronic readout and biological processes. Founded in 2015, headquartered in San Diego, United States, The company has raised $32.0M at the Series A stage, backed by investors including PTK Capital, JAM Fund. The company operates in the Life Sciences > Genomics, Life Sciences > Life Sciences Platforms and Tools, Semiconductors > Sensors sector. with business models spanning Genomics > Enabling Technologies > Instrument Systems > Nucleic Acid Analysis > Sequencing, Life Sciences Platforms and Tools > Instruments > Genomics > Nucleic Acid Sequencing. serving markets in United States. Provider of diagnostic sensor solutions for nucleic acid sequencing..
Roswell
Series ARoswell Biotech develops biotechnology platforms integrating semiconductor technology with molecular biology for life science applications. The company creates innovative biosensor technologies that enable single-molecule detection and analysis at scale, bridging the gap between electronic readout and biological processes. Founded in 2015, headquartered in San Diego, United States, The company has raised $32.0M at…
About
Business model
Genomics > Enabling Technologies > Instrument Systems > Nucleic Acid Analysis > Sequencing,
Life Sciences Platforms and Tools > Instruments > Genomics > Nucleic Acid Sequencing,
Sensors > Generic Sensor Developers > Biological > Diagnostics
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.